1 hour ago
Natera (NTRA) Stock Soars 7% Following Japanese Regulatory Milestone for Signatera
Natera (NTRA) stock rose 7.67% after Japan approved Signatera for colorectal cancer MRD testing, marking the country's first authorized test of its kind.
The post Natera (NTRA) Stock Soars 7% Following Japanese Regulatory Milestone for Signatera appeared first on Blockonomi.
Source: Blockonomi →Related News
- 11 minutes ago
SpaceX (SPCX) Stock Plunges 10.6% Despite Securing $6.3B AI Computing Contract
- 18 minutes ago
ASML (ASML) Stock Plummets 8% Amid U.S.-China Export Control Tensions
- 27 minutes ago
Kalshi Files Federal Lawsuit Against Illinois Prediction Market Regulations
- 30 minutes ago
ARK Invest Snaps Up Palantir (PLTR), Amazon (AMZN) and Big Tech Giants
- 36 minutes ago
Strategy (MSTR) Stock Plunges Under $100 as Bitcoin Slide Intensifies Pressure